Added to YB: 2025-09-09
Pitch date: 2025-09-05
GUTS [bullish]
Fractyl Health, Inc.
+142.74%
current return
Author Info
Anders Research shares equity research primarily focused on micro/small/mid-cap biotechnology. We follow companies with mechanistically differentiated approaches to large market opportunities, with special focus in neuroscience. Sign up for the newsletter.
Company Info
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
Market Cap
$200.1M
Pitch Price
$0.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.13
P/E
-0.63
EV/Sales
61.5K
Sector
Health Care Equipment and Supplies
Category
special_situation
Fractyl Health: One-Time Procedure to Lock-In GLP-1 Weight Loss; High Risk, High Reward
GUTS: Medical device co targeting GLP-1 weight rebound w/ one-time Revita procedure. 45-patient placebo-controlled data due Sept showing if procedure prevents 5-6% weight regain vs maintaining <1% gain. Open-label showed 0.46% median regain in 13 patients. $70M mcap, tight cash runway to 1Q26.
Read full article (13 min)